Cancer Research KI updates and upcoming events
|
|
|
|
Welcome new Executive Board members of
Cancer Research KI
|
|
Associate Professor
Simon Ekman
Dept. of Oncology & Pathology
|
|
|
Associate Professor
Päivi Östling
Dept. of Oncology & Pathology
|
|
|
Professor
Qian Pan Hammarström
Dept. of Biosciences & Nutrition
|
|
|
|
|
A warm welcome to the new Cancer Research KI Executive Board members!
Simon Ekman's group focuses on lung cancer and includes clinical, translational, and preclinical studies. They aim to find new treatment targets and biomarkers as therapy resistance is a common clinical issue when treating lung cancer patients. They also research brain metastasis in lung cancer within a patient group with a poor prognosis (photo: Andreas Andersson).
Päivi Östling has more than 10 years of research experience in the field of precision cancer medicine research. She is one of the Scientific Leads of Precision Medicine and has been responsible for establishing a functional precision medicine platform at SciLifeLab. Together with Olli Kallioniemi, she leads a group focusing on individualized drug profiling including multi-omics in acute myeloid leukemia, ovarian and bladder cancer as well as pediatric tumors.
Qian Pan Hammarström's group studies human B cells in health and disease, with a focus on primary immunodeficiency and B cell malignancy. Currently, she is also leading an EU consortium on antibody therapy for COVID-19.
|
Seminar series on industry-academia collaboration
|
|
Cancer Research KI strives to accelerate innovation and industrial collaborations to translate the research findings into a new treatments strategy.
Cancer research KI launches a seminar series that aims to promote and facilitate industrial-academia collaborations. During the first meeting, there will be a chance to learn about reasons and motivation to start this collaboration, the process of working with industry, and an opportunity to mingle.
As the seminar series will continue please let us know if you have suggestions on topics that we should address by sending your ideas to cancerresearchki@ki.se. For all the details and a programme for the next seminar please visit our website.
Please register by sending an e-mail to cancerresearchKI@ki.se by Monday 17th of January
Date: 20 January 2022 | Location: Inghesalen, Tomtebodavägen 18a, 171 65, Solna Campus and Zoom (a link is provided after the registration).
|
|
|
|
|
|
The annual Cancer Research KI retreat is open for registration! Please remember to send your abstract to cancerresearchki@ki.se (all abstract submission details follow after the registration).
The XIXth Cancer Research KI Retreat will take place May 23-24, 2022 at Djurönäset in the Stockholm archipelago. The retreat is open for all KI/KUH students, post-docs, researchers, principal investigators, and healthcare professionals with an interest in cancer research and in the current and future activities of Cancer Research KI.
For more information please visit the retreat website. To learn more about the previous editions please visit the retreat archive.
We hope to see you there!
Deadline for registration: February 21, 2022
|
|
|
|
Videos from "En dag för cancerforskning" are available on the CRKI webiste
|
|
Cancer Research KI organised "En dag för cancerforskning" during spring semester this year. The meeting was digital, and it was dedicated for the general public to present and talk about cutting-edge cancer research. Now, it is possible to relive this day and listen to outstanding presentations as the videos are updated on the CRKI website. The recording and subtitles are in Swedish.
|
|
|
|
Best wishes for a joyful Holiday & a Happy New Year
|
|
|
|
|
Cancer Research KI wishes you all the best for Christmas and Happy New Year 2022. We hope that the New Year brings many more cancer research discoveries, effective treatments, and new collaborations. See you in 2022!
|
|
|
|
|
Recent Research Publications
|
| • |
Xiaolei Zhou (Dept. of Microbiology, Tumor and Cell Biology) Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity. Cancer Discovery, December 2021.
| | • |
Dawei Song (Dept. of Oncology & Pathology) IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma. Oncogene, November 2021.
| | • |
Trausti Oskarsson (Dept of Women's and Children's Health) Skeletal adverse events in childhood cancer survivors: An Adult Life after Childhood Cancer in Scandinavia cohort study. International Journal of Cancer, December 2021.
| | • |
Janne Lehtiö (Dept. of Oncology & Pathology) Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms. Nature Cancer, November 2021.
| | • |
Belkić Dževad (Dept. of Oncology & Pathology) One electron-capture in collisions of fast nuclei with biomolecules of relevance to ion therapy. Advances in Quantum Chemistry, November 2021.
| | • |
Belkić Dževad, Belkić Karen (Dept. of Oncology & Pathology) Derivative NMR spectroscopy for J-coupled resonances in analytical chemistry and medical diagnostics. Advances in Quantum Chemistry, November 2021.
| | • |
Belkić Dževad, Belkić Karen (Dept. of Oncology & Pathology) High-Resolution at 3T for in vivo derivative NMR spectroscopy in medical diagnostics of ovarian tumor: Exact quantification by shape estimations. Journal of Mathematical Chemistry, November 2021.
| | • |
Belkić Dževad, Belkić Karen (Dept. of Oncology & Pathology) In vivo derivative NMR spectroscopy for simultaneous improvements of resolution and signal-to-noise ratio: Case study, glioma. Journal of Mathematical Chemistry, October 2021.
|
Any cancer-related publications from a KI-based researcher (corresponding author must be from KI) that you wish to be advertised through our newsletter please send in the format shown above to our email: cancerresearchki@ki.se
|
|
|
|
|
Cancer Research KI awards research grants in several categories to promote excellent young researchers, clinical research, innovative research and joint international research projects. All grants are announced openly and the applications undergo external review.
|
|
|
|
|
Please send us your open positions for Master projects, PhD candidates and postdocs so that we can advertise them to our Cancer Research KI community.
|
|
|
|
|
|
|
|
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, conducted by some 350 research groups at multiple campuses and departments. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
|
|
|
|
|
|
|
